-
Mayo Clinic Researchers Find Survival Improves When Herceptin is Used with Chemotherapy
Share this:
Herceptin has proven to be a life-saving drug for women with HER2+ breast cancer, which makes up 20 percent to 25 percent of all cases. But it has not been known whether the agent should be given with, or after, chemotherapy in women who have already had surgery to remove tumors.
The answer is now known, based on a key trial headed by Mayo Clinic researchers, who tested the two different regimens head-to-head. Lead investigator Edith Perez, M.D., Professor of Medicine at Mayo Clinics campus in Jacksonville, Fla., shares more on this study.
Share this:
Related articles
The types of cancer that occur in children often are different from those in adults. Childhood cancers usually are not linked to lifestyle or environmental ...
September is Childhood Cancer Awareness Month. The most common type of childhood cancer is acute lymphocytic leukemia (ALL), a blood and bone marrow cancer that creates immature white ...
DEAR MAYO CLINIC: I recently heard about a type of skin cancer called Merkel cell carcinoma. I'm not familiar with this condition. Can you explain ...